Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Other Accumulated Expenses (2010 - 2012)

Updated

Jazz Pharmaceuticals (JAZZ) recorded Other Accumulated Expenses of $18.87 million in Q2 2012, up 130.7% from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Other Accumulated Expenses (2010 - 2012) Analysis & Trends

At the end of FY2011, Jazz Pharmaceuticals reported Other Accumulated Expenses of $2.44 million, up 135.7% from FY2010.

  • Across earlier years, Other Accumulated Expenses came in at $1.04 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Jazz Pharmaceuticals 15.30 Bn 9.12 Bn 1.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 18.87 Mn
Mar 31, 2012 8.18 Mn
Dec 31, 2011 2.44 Mn
Dec 31, 2010 1.04 Mn
API Access

Jazz Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=JAZZ&period=max&api_key=YOUR_API_KEY